1. Effect of a Ketohexokinase Inhibitor (PF‐06835919) on In Vivo OATP1B Activity: Integrative Risk Assessment Using Endogenous Biomarker and a Probe Drug. Issue 3 (9th May 2022) Authors: Tess, David A.; Kimoto, Emi; King‐Ahmad, Amanda; Vourvahis, Manoli; Rodrigues, A. David; Bergman, Arthur; Qui, Ruolun; Somayaji, Veena; Weng, Yan; Fonseca, Kari R.; Litchfield, John; Varma, Manthena V. S. Journal: Clinical pharmacology & therapeutics Issue: Volume 112:Issue 3(2022) Page Start: 605 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗